- Activity pressure is positive on the latest completed week.
VLA
VIE
Week ended 07 Aug 2026
Weekly Investor Report
Valneva SE · Healthcare · Biotechnology
Latest close
2.37 EUR
2.4%
latest week
Weekly setup
Mixed setup
The weekly trend is not active. Price is -23.2% below the Trend Line and sits at 9.7% of its 52-week range. The latest completed week returned 2.4%, after a 7.5% four-week move. The latest news-sentiment score is 50/100. Near-term considerations: volume confirmation is below normal.
Setup score
32
out of 100
Latest Close
2.37 EUR
7 Aug 2026
1W Return
2.4%
latest completed week
4W Return
7.5%
short-term follow-through
12W Return
-4.6%
quarterly tape
Trend Breadth
59.6%
31 of 52 weeks active
Volume Ratio
0.7x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Activity pressure is weak, so confirmation is not yet broad enough.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
2.4%
Latest completed week; four-week move 7.5%.
Indicator stack
33/61
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Recent
Activity-pressure buy-signal status for institutional accumulation timing.
News sentiment
50/100
5 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is -23.2% below the Trend Line and sits at 9.7% of its 52-week range. The latest completed week returned 2.4%, after a 7.5% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 0.7x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.0212-week average 0.04
12-week confirmation
Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure2/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.02Current proprietary activity-pressure read.
Buy signals1Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 7.5% over four weeks, -4.6% over 12 weeks, and -37.0% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year31
Trend breadth59.6%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure0.09Latest activity-pressure read.
Pressure change114.9%Four-week change in activity pressure.
Leadership-46.24Latest relative-leadership reading.
RS change8.9%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment50/100
Weighted news tone is neutral across 5 relevant articles.
0 positive · 5 neutral · 0 negativePatient CapitalRecent
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
Recent buy signal in the last 8 weeks
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-55.4%Distance below the 52-week high.
13-week volatility5.3%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher11 of 2615 weeks finished lower.
Best week+10.1%Week of 20 Feb.
Worst week-37.5%Week of 27 Mar.
Latest week+2.4%Week of 7 Aug.
Shape of recent returns
Strong gains6
Modest gains5
Flat weeks0
Modest losses9
Sharp losses6
Recent vol5.3%13-week weekly-return volatility.
Base vol10.2%52-week weekly-return volatility.
Up/down split25/27Count of positive and negative weeks in the 52-week window.
Average skew7.1% / -7.2%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorAT Healthcare
4-week rank- / 100
Group average2.6%
Trend breadth47.0%
Trend47.0%active weekly trend signals
MD73.0%positive activity pressure
RS10.0%positive relative leadership
Four-week leaders
IndustryAT Biotechnology
4-week rank3 / 21
Group average-4.6%
Trend breadth19.0%
Trend19.0%active weekly trend signals
MD42.9%positive activity pressure
RS4.8%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape29/100
Trend, activity pressure, participation, and risk combine to a 29/100 tape read.
Indicator analysis12/100Latest 12-week confirmation: trend 0/12, activity pressure 2/12, relative leadership 0/12.
Activity pressure 0.02; No reversal markers Factors50/100No published factor snapshot is available yet.
Patient CapitalRecentActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
Recent buy signal in the last 8 weeks Sentiment50/100Weighted news tone is neutral across 5 relevant articles.
€5.28: That's What Analysts Think Valneva SE (EPA:VLA) Is Worth After Its Latest Results Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 2.37 EUR | 2.4% | 3.08 EUR | 3.53 EUR | 0.09 | -46.24 | 15.7K | Off |
| 31 Jul 2026 | 2.31 EUR | 9.4% | 3.14 EUR | 3.56 EUR | 0.01 | -46.59 | 6.6K | Off |
| 24 Jul 2026 | 2.11 EUR | -1.8% | 3.19 EUR | 3.59 EUR | -0.07 | -51.63 | 6.6K | Off |
| 17 Jul 2026 | 2.15 EUR | -2.3% | 3.24 EUR | 3.62 EUR | -0.33 | -50.64 | 22.7K | Off |
| 10 Jul 2026 | 2.20 EUR | -6.6% | 3.29 EUR | 3.65 EUR | -0.60 | -50.78 | 34.1K | Off |
| 3 Jul 2026 | 2.35 EUR | 5.7% | 3.34 EUR | 3.68 EUR | -0.92 | -48.30 | 6.1K | Off |
| 26 Jun 2026 | 2.23 EUR | -3.3% | 3.39 EUR | 3.70 EUR | -1.20 | -50.11 | 320 | Off |
| 19 Jun 2026 | 2.30 EUR | 0.6% | 3.45 EUR | 3.73 EUR | -1.16 | -49.67 | 6.8K | Off |
| 12 Jun 2026 | 2.29 EUR | -3.0% | 3.50 EUR | 3.76 EUR | -1.14 | -48.13 | 10.0K | Off |
| 5 Jun 2026 | 2.36 EUR | -11.0% | 3.55 EUR | 3.79 EUR | -1.01 | -45.38 | 6.9K | Off |
| 29 May 2026 | 2.65 EUR | 6.3% | 3.59 EUR | 3.81 EUR | -1.00 | -39.64 | 40.7K | Off |
| 22 May 2026 | 2.50 EUR | 0.6% | 3.64 EUR | 3.83 EUR | -1.12 | -41.91 | 30.1K | Off |
| 15 May 2026 | 2.48 EUR | 2.7% | 3.69 EUR | 3.85 EUR | -1.18 | -41.40 | 109.7K | Off |
| 8 May 2026 | 2.42 EUR | 4.0% | 3.75 EUR | 3.87 EUR | -1.41 | -43.48 | 33.6K | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.